Printer Friendly

A drug to stop diabetes' onset?

In an effort to stem the increasing prevalence of type 1 diabetes, researchers are developing a drug that could protect susceptible individuals from the disease.

People with type 1 diabetes need frequent insulin injections to control their blood sugar because their immune system has destroyed the insulin-producing cells in their pancreas. One of the proteins in the cascade of reactions responsible for killing pancreatic cells is called macrophage migration inhibitory factor (MIF).

Medicinal chemist Yousef Al-Abed of the North Shore-Long Island Jewish Research Institute in Manhasset, N.Y., led recent effort in which he and his colleagues identified a compound, called ISO-1, that blocks the activity of MIF. When the researchers treated mice genetically altered to develop diabetes, a 10-day course of the drug prevented the disease's onset in 90 percent of the mice. What's more, the drug's protective effects lasted up to 2 months after the treatment ended.

Although several research groups are developing drugs for prevention, most have concentrated on antibody-based vaccines. Any successful antibody vaccine will require trained health care workers to administer multiple injections, Al-Abed says. Because ISO-1 is a small molecule, it could be taken in a pill and have long-lasting effects.

Candidates for the treatment would include people with certain protein or gene markers in their blood that predict increased risk of diabetes, says Al-Abed, but he cautions that it could be 10 years before ISO-1 reaches patients.--A.G.
COPYRIGHT 2004 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Medicine
Publication:Science News
Date:Apr 17, 2004
Previous Article:Bacteria churn out new type of electronic paper.
Next Article:Flame-retardant cotton gets a boost from clay.

Related Articles
Diabetes aurtoimmunity seen, stopped.
Diabetes antibody best marker so far.
Protein may predict diabetic complications.
Brisk steps can reduce diabetes risk.
Cell transplants combat diabetes in mice.
Rezulin: fast track to failure.
Medicines for people with diabetes.
Blood sugar fix: can novel drugs rescue insulin-making cells?
Tackling stroke and heart risks.
New diabetes drug passes early tests.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters